National rules on medicine advertising
1 min read3 pages below
This branch covers national medicine-advertising frameworks, organised by jurisdiction and by their development or application. It covers the UK framework in 2007, the history of US consumer drug advertising through 2008, and US promotional review and enforcement in 2009–2019. General promotional-copy requirements, industry codes for dealings with health professionals, device promotion and responses to unsolicited off-label enquiries sit outside this branch.
- UK rules on medicine advertising — statutory and code controls, audiences, claims, required information, formats and distribution in 2007
- How the US rules on drug advertising came about — legislative history, consumer-advertisement categories and evidence on their effects through 2008
- What the US regulator reviews and acts on — FDA review, violations, pre-approval communication, presentation, online promotion and reprints in 2009–2019